KYMERA THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at KYMERA THERAPEUTICS is $120,000, based on 21 certified filings from FY 2021 to FY 2026. This is equal to the national H-1B median salary of $120,000. Compensation at KYMERA THERAPEUTICS reflects their market positioning, with entry-level roles starting around $95,000 and senior positions reaching $190,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at KYMERA THERAPEUTICS range from $82,555 at the 10th percentile to $190,000 at the 90th percentile, showing a $107,445 spread across experience levels and roles. The 25th percentile is $95,000 and the 75th percentile is $160,000.

Yes, KYMERA THERAPEUTICS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), KYMERA THERAPEUTICS filed 4 H-1B labor condition applications with 4 certified and 0 denied, at a median salary of $230,000. Across FY 2021–2026, they have filed 21 total H-1B applications with 21 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. KYMERA THERAPEUTICS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), KYMERA THERAPEUTICS filed 4 H-1B applications, with 4 certified and 0 denied. Over 6 years of data, KYMERA THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

KYMERA THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 21 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating KYMERA THERAPEUTICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating KYMERA THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

KYMERA THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 21 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles KYMERA THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at KYMERA THERAPEUTICS:

The most frequently sponsored role is Research Scientist with 5 filings at a median salary of $105,872. This is followed by Associate Research Scientist (5 filings) and Associate Director, Translational Medicine.

KYMERA THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where KYMERA THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top KYMERA THERAPEUTICS H-1B locations:

The largest H-1B hub for KYMERA THERAPEUTICS is Watertown, MA with 21 filings at a median salary of $120,000.

KYMERA THERAPEUTICS's median H-1B salary has increased by +179% from FY 2021 ($82,555) to FY 2026 ($230,000). Tracking salary trends over time reveals how KYMERA THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at KYMERA THERAPEUTICS.

Year-by-year breakdown:

• FY 2022: $95,000 (3 certified)
• FY 2023: $135,000 (4 certified)
• FY 2024: $140,000 (2 certified)
• FY 2025: $160,000 (5 certified)
• FY 2026: $230,000 (4 certified)

This 179% growth reflects strong compensation adjustments at KYMERA THERAPEUTICS, keeping pace with market demands for H-1B talent.

KYMERA THERAPEUTICS primarily files H-1B applications at Wage Level II, accounting for 62% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making KYMERA THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 86% of positions at Level II or higher, KYMERA THERAPEUTICS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

KYMERA THERAPEUTICS's median H-1B salary of $120,000 is equal to the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating KYMERA THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare KYMERA THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

KYMERA THERAPEUTICS's H-1B salaries are competitive with industry averages. The 21 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. KYMERA THERAPEUTICS files 14% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 21 certified filings, KYMERA THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.